Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongbing Li

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Toxicology Reports|January 13, 2025
<i>Jatropha curcas</i> seed oil for possible human consumption: A toxicological assessment of its phorbol estersXinyuan Cao, Xiaoyang Wei, Yuanyuan Shao, et al.
Current Medicinal Chemistry|January 8, 2025
Unveiling the Role of SLC6A17 in Lung Adenocarcinoma: Prognosis, Pathways, and Therapeutic ImplicationsPing Chen, Jingbo Li, JiFan Wen, et al.
Current Medicinal Chemistry|November 1, 2024
LNX1-AS2 as a Key Prognostic and Immunotherapy Response Biomarker for Lung AdenocarcinomaXiuxiu Wang, Guanzhong Yan, Xiaoying Zhang, et al.
Current Medicinal Chemistry|July 3, 2025
Exploring MFSD9: From Expression Patterns to Therapeutic Implications in LUADQian Wang, Meijuan Zhang, Yan Xiang, et al.
Current Medicinal Chemistry|August 28, 2025
Decoding PRTFDC1's Role in Lung Adenocarcinoma: From Gene Expression to Clinical ImplicationsJian Yao, Qiang Zhang, Chunhe Zhong, et al.
Environmental Pollution (Barking, Essex : 1987)|June 21, 2020
Formaldehyde and VOC emissions from plywood panels bonded with bio-oil phenolic resinsLiangliang Jia, Jie Chu, Jing Li, et al.
International Journal of Environmental Research and Public Health|July 9, 2022
Spatial Pattern Analysis of Xinjiang Tourism Resources Based on Electronic Map Points of InterestYao Chang, Dongbing Li, Zibibula Simayi, et al.
Current Medicinal Chemistry|February 20, 2025
DDX59-AS1: A Novel Prognostic Biomarker and Immunotherapy Predictor in Lung AdenocarcinomaYanli Wang, Wei Li, Su Wei, et al.
Recent Patents on Anti-Cancer Drug Discovery|August 28, 2024
Comprehensive Analysis and Experimental Validation of TLL2 as a Potential New Prognostic Biomarker Associated with Immune Infiltration in Lung AdenocarcinomaJing Jiang, Zhongye Du, Haijuan Tang, et al.
Current Computer-Aided Drug Design|March 7, 2025
HOXC-AS1: A Key Biomarker for Prognosis and Immunotherapy in Lung AdenocarcinomaHaiyin Ye, Xiao Yang, Qiu Huang, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Toxicology Reports|January 13, 2025
<i>Jatropha curcas</i> seed oil for possible human consumption: A toxicological assessment of its phorbol estersXinyuan Cao, Xiaoyang Wei, Yuanyuan Shao, et al.
Current Medicinal Chemistry|January 8, 2025
Unveiling the Role of SLC6A17 in Lung Adenocarcinoma: Prognosis, Pathways, and Therapeutic ImplicationsPing Chen, Jingbo Li, JiFan Wen, et al.
Current Medicinal Chemistry|November 1, 2024
LNX1-AS2 as a Key Prognostic and Immunotherapy Response Biomarker for Lung AdenocarcinomaXiuxiu Wang, Guanzhong Yan, Xiaoying Zhang, et al.
Current Medicinal Chemistry|July 3, 2025
Exploring MFSD9: From Expression Patterns to Therapeutic Implications in LUADQian Wang, Meijuan Zhang, Yan Xiang, et al.
Current Medicinal Chemistry|August 28, 2025
Decoding PRTFDC1's Role in Lung Adenocarcinoma: From Gene Expression to Clinical ImplicationsJian Yao, Qiang Zhang, Chunhe Zhong, et al.
Environmental Pollution (Barking, Essex : 1987)|June 21, 2020
Formaldehyde and VOC emissions from plywood panels bonded with bio-oil phenolic resinsLiangliang Jia, Jie Chu, Jing Li, et al.
International Journal of Environmental Research and Public Health|July 9, 2022
Spatial Pattern Analysis of Xinjiang Tourism Resources Based on Electronic Map Points of InterestYao Chang, Dongbing Li, Zibibula Simayi, et al.
Current Medicinal Chemistry|February 20, 2025
DDX59-AS1: A Novel Prognostic Biomarker and Immunotherapy Predictor in Lung AdenocarcinomaYanli Wang, Wei Li, Su Wei, et al.
Recent Patents on Anti-Cancer Drug Discovery|August 28, 2024
Comprehensive Analysis and Experimental Validation of TLL2 as a Potential New Prognostic Biomarker Associated with Immune Infiltration in Lung AdenocarcinomaJing Jiang, Zhongye Du, Haijuan Tang, et al.
Current Computer-Aided Drug Design|March 7, 2025
HOXC-AS1: A Key Biomarker for Prognosis and Immunotherapy in Lung AdenocarcinomaHaiyin Ye, Xiao Yang, Qiu Huang, et al.
Pageof 9